OQROGet OQRO Pro
Insider trade

Corcept Therapeutics (CORT)Chief Business Officer sold ~$556K

Gary Charles Robb, Chief Business Officer at Corcept Therapeutics, sold ~$556K of Corcept Therapeutics shares.

~$556K
Approx. value · 11K sh @ $50.50
20K
Holds after · shares reported
Traded
Jan 2, 2025
Filed
Jan 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 1, 2024InsiderOfficer sold ~$323K of CORT shares in the open market
  2. Nov 4, 2024InsiderOfficer sold ~$166K of CORT shares in the open market
  3. Nov 11, 2024InsiderDirector sold ~$132K of CORT shares in the open market
  4. Nov 22, 2024Insider · 2 peopleInsiders: 2 sales (~$227K)
  5. Dec 10, 2024InsiderDirector sold ~$131K of CORT shares in the open market
  6. Jan 2, 2025 · this disclosureInsiderOfficer sold ~$556K of CORT shares in the open market

What came next

  1. Jan 2, 2025Insider · 2 peopleInsiders: 2 sales (~$1.3M)
  2. Jan 10, 2025InsiderDirector sold ~$111K of CORT shares in the open market
  3. Feb 3, 2025Insider · 2 peopleInsiders: 2 sales (~$1.7M)
  4. Feb 10, 2025InsiderDirector sold ~$150K of CORT shares in the open market
  5. Mar 3, 2025Insider · 3 peopleInsiders: 3 sales (~$1.6M)
  6. Mar 4, 2025InsiderOfficer sold ~$1.18M of CORT shares in the open market
  7. Mar 10, 2025InsiderDirector sold ~$118K of CORT shares in the open market
  8. Mar 24, 2025Insider · 3 peopleInsiders: 3 sales (~$248K)
  9. Mar 31, 2025Insider · 3 peopleInsiders: 7 sales (~$33.5M)
  10. Apr 1, 2025Insider · 4 peopleInsiders: 4 sales (~$260K)
  11. Apr 10, 2025InsiderDirector sold ~$154K of CORT shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Corcept Therapeutics

For Corcept Therapeutics, OQRO holds 64 insider filings (SEC Form 4 or Form 144) and 5 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CORT page.

Other recent filings by Gary Charles Robb, Chief Business Officer

The full history of Gary Charles Robb, Chief Business Officer is on the profile page.

How this filing works

Other disclosures at Corcept Therapeutics

Everything OQRO holds on this company is on its CORT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data